IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GENNARELLI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.447
AS - Asia 10.112
EU - Europa 8.355
SA - Sud America 2.175
AF - Africa 238
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 24
AN - Antartide 1
Totale 41.383
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.124
CN - Cina 3.703
SG - Singapore 3.256
UA - Ucraina 1.999
BR - Brasile 1.790
IT - Italia 1.147
HK - Hong Kong 1.144
PL - Polonia 1.124
DE - Germania 1.091
FR - Francia 771
VN - Vietnam 765
FI - Finlandia 605
GB - Regno Unito 552
TR - Turchia 372
RU - Federazione Russa 333
IE - Irlanda 328
IN - India 232
AR - Argentina 163
CA - Canada 147
BD - Bangladesh 135
MX - Messico 107
ZA - Sudafrica 80
IQ - Iraq 70
ID - Indonesia 67
SE - Svezia 65
EC - Ecuador 56
NL - Olanda 56
ES - Italia 53
PK - Pakistan 51
JP - Giappone 45
BE - Belgio 43
CZ - Repubblica Ceca 42
AT - Austria 41
CO - Colombia 38
VE - Venezuela 38
SA - Arabia Saudita 37
MA - Marocco 34
CL - Cile 32
PY - Paraguay 28
AU - Australia 27
NG - Nigeria 26
KE - Kenya 24
UZ - Uzbekistan 24
IR - Iran 22
EU - Europa 21
JO - Giordania 21
LT - Lituania 20
EG - Egitto 18
CH - Svizzera 16
PE - Perù 15
PH - Filippine 15
TN - Tunisia 15
AE - Emirati Arabi Uniti 14
IL - Israele 14
JM - Giamaica 14
NP - Nepal 14
KR - Corea 11
AZ - Azerbaigian 10
BG - Bulgaria 10
BH - Bahrain 10
KZ - Kazakistan 10
UY - Uruguay 10
CR - Costa Rica 9
DZ - Algeria 9
KG - Kirghizistan 9
OM - Oman 9
PA - Panama 9
DO - Repubblica Dominicana 8
ET - Etiopia 8
HN - Honduras 8
MU - Mauritius 8
TT - Trinidad e Tobago 8
AL - Albania 7
HU - Ungheria 7
MY - Malesia 7
RO - Romania 7
TW - Taiwan 7
SV - El Salvador 6
SY - Repubblica araba siriana 6
BY - Bielorussia 5
GE - Georgia 5
KW - Kuwait 5
LV - Lettonia 5
PT - Portogallo 5
AO - Angola 4
BO - Bolivia 4
LU - Lussemburgo 4
NO - Norvegia 4
PS - Palestinian Territory 4
TH - Thailandia 4
BB - Barbados 3
CI - Costa d'Avorio 3
DK - Danimarca 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LK - Sri Lanka 3
LY - Libia 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
Totale 41.355
Salva come PNG Salva come JPEG
Città #
Fairfield 2.491
Woodbridge 1.991
Singapore 1.799
Ashburn 1.723
Jacksonville 1.431
Houston 1.286
Hong Kong 1.137
Warsaw 1.118
Ann Arbor 1.076
Cambridge 1.007
Seattle 942
Wilmington 831
Chandler 654
Beijing 631
San Jose 606
Princeton 602
The Dalles 591
Nanjing 517
New York 375
Dublin 323
Los Angeles 322
Brescia 321
Lauterbourg 304
Istanbul 293
Helsinki 288
Ho Chi Minh City 267
Dearborn 230
Nanchang 212
Des Moines 205
Munich 171
São Paulo 164
Buffalo 159
Shenyang 157
Milan 145
Changsha 142
Hebei 139
Hanoi 138
San Diego 132
Moscow 126
Shanghai 120
Redondo Beach 115
Council Bluffs 110
Lancaster 107
San Francisco 105
Jinan 104
Chicago 99
Tianjin 94
Dallas 87
Jiaxing 86
Santa Clara 75
London 74
Orem 74
Dong Ket 68
Verona 66
Hangzhou 65
Kunming 64
Turku 61
Norwalk 57
Boardman 56
Frankfurt am Main 56
Guangzhou 53
Rio de Janeiro 53
Nuremberg 52
Zhengzhou 52
Lanzhou 50
Brooklyn 48
Ningbo 48
Belo Horizonte 47
Toronto 45
Johannesburg 44
Mexico City 43
Montreal 43
Brussels 42
Haikou 39
Rome 39
Tokyo 39
Haiphong 36
Atlanta 35
Romola 34
San Mateo 34
Bolzano 33
Denver 32
Brasília 30
Chennai 30
Jakarta 30
Phoenix 29
Stockholm 29
Leawood 27
Brno 26
Abuja 25
Dhaka 25
Porto Alegre 25
Campinas 24
Kocaeli 24
Manchester 24
Mumbai 24
Naples 24
Washington 24
Da Nang 23
Salvador 23
Totale 28.196
Salva come PNG Salva come JPEG
Nome #
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 320
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 318
New Copy Number Variations in Schizophrenia 315
Compound heterozygosity for a large CNV deletion and a rare missense mutation in the FSTL5 gene of a patient affected by schizophrenia. 296
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 263
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 249
Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables 248
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation 232
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 226
Copy number variants in attention-deficit hyperactive disorder: identification of the 15q13 deletion and its functional role. 224
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 223
Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia 223
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients 217
New biological pathways for major depression: gene expression decomposition in G x E components 209
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 206
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 206
Genomic restricted maximum likelihood (GREML) analysis to estimate the heritability of response/resistance in major depressive disorder (MDD) 204
Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. 201
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 194
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 192
The role of the potassium channel gene KCNK2 in major depressive disorder 189
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 185
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder 185
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. 183
Gene per la neuregulina 1 e schizofrenia: ulteriori evidenze di associazione 183
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 180
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 179
Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. 179
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 177
The role of GRIK4 gene in treatment-resistant depression 176
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 175
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 174
Glucose metabolism alterations in patients with bipolar disorder 172
3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. 171
Next Generation Sequencing Analysis in Early Onset Dementia Patients 171
A putative regulatory subunit (NR3A) of the NMDA receptor complex as candidate gene for susceptibility to schizophrenia: a case-control study. 171
Analysis of Copy Number Variations in Schizophrenia Italian Patients 170
A genome-wide investigation of SNPs and CNVs in schizophrenia. 170
BDNF Val66Met polymorphism and protein levels in amniotic fluid. 170
Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline 'Predictors' and Longitudinal 'Targets' 169
The Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders 169
Functional study of a novel homozygous mutation in the GAD1 gene, detected in a patient with schizophrenia. 167
Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. 167
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 166
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 165
The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study. 164
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 163
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 163
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. 162
Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. 160
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 160
Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study 159
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. 159
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 159
MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder 158
Acute Stress Responsiveness of the Neurotrophin BDNF in the Rat Hippocampus is Modulated by Chronic Treatment with the Antidepressant Duloxetine. 157
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 157
Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. 154
Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. 153
Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus 151
Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels 151
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia 151
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 151
An association of GRIK3 Ser310Ala functional polymorphism with personality traits. 150
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series 149
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial. 148
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 147
Immune and metabolic alterations in first episode psychosis (FEP) patients 147
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease 146
Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients 146
The influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits. 145
ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder. 145
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. 145
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 144
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD). 144
Exome sequencing of schizophrenia patients with high level of homozygosity identifies a homozygous novel mutation that reduces the glutamate acid decarboxylase 67 (GAD67) activity 144
PCLO gene: Its role in vulnerability to major depressive disorder. 143
Erbb3 leukocytes mRNA levels as biomarker of Major Depression. 143
VEGF Haplotypes are Associated with Increased Risk to Progressive Supranuclear Palsy and Corticobasal Syndrome. 142
Blood microRNA changes in depressed patients during antidepressant treatment. 142
Heterozygous TREM2 mutations in frontotemporal dementia 142
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence. 141
The Expression of VGF is Reduced in Leukocytes of Depressed Patients and it is Restored by Effective Antidepressant Treatment 141
α-Synuclein and Glia in Parkinson’s Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System? 141
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 141
A single polymerase chain reaction-based protocol for detecting normal and expanded alleles in myotonic dystrophy. 140
Possible Influence of a Non-Synonymous Polymorphism Located in the NGF Precursor on Susceptibility to Late-Onset Alzheimer's Disease and Mild Cognitive Impairment. 140
INFLAMMATORY AND NEUROTROPHIC FACTORS UNBALANCE IN LEUKOCYTES OF FIRST EPISODE PSYCHOSIS PATIENTS 139
Association study between schizophrenia and the AMPA genes GRIA1, GRIA2 AND GRIA4 138
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: Comparison with methylphenidate. 138
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 138
Genetic variations and association. 137
Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients 137
Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients 137
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 137
Seizure Adequacy Markers and the Prediction of Electroconvulsive Therapy Response 136
Influence of GRIK4 genetic variants on the electroconvulsive therapy response 136
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation. 134
Leucine-Rich Repeat Kinase-2 Controls the Differentiation and Maturation of Oligodendrocytes in Mice and Zebrafish 133
Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum. 133
Totale 17.190
Salva come PNG Salva come JPEG
Categoria #
all - tutte 194.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 194.558
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.174 0 0 0 0 0 0 0 0 0 414 550 210
2021/20222.396 158 541 56 56 14 98 206 142 172 238 206 509
2022/20232.084 349 12 31 146 190 620 6 208 315 32 94 81
2023/20242.135 127 52 188 131 95 349 60 72 588 37 37 399
2024/20255.439 47 55 82 615 592 516 392 189 513 585 1.034 819
2025/202610.746 1.042 1.622 852 1.769 1.142 762 1.602 471 725 759 0 0
Totale 41.915